Zhejiang Haizhou Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GUAIFENESIN, with a corresponding US DMF Number 29179.
Remarkably, this DMF maintains an Active status since its submission on March 13, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 16, 2025, and payment made on May 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II